AngioDynamics Inc reports results for the quarter ended in February - Earnings Summary

AngioDynamics

30/03/2023 14:31

* AngioDynamics Inc  ANGO.OQ  reported a quarterly adjusted
loss
of 3 cents​​ per share for the quarter ended in February. The
mean expectation of four analysts for the quarter was for a loss
of one cent per share.
    * Revenue rose 9.1% to $80.71 million from a year ago;
analysts
expected $83.19 million. 
    * AngioDynamics Inc's reported EPS for the quarter was a
loss
of 24 cents​.
    * The mean earnings estimate of analysts had fallen by
about 200%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AngioDynamics Inc shares had fallen by 9.4% this quarter.
    * The company reported a quarterly loss of $9.49 million.
    * Wall Street's median 12-month price target for
AngioDynamics Inc
is $24.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 30 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Feb. 28 2023      -0.01          -0.03          Missed
 Nov. 30 2022      -0.01          0.01           Beat
 Aug. 31 2022      -0.02          -0.06          Missed
 May. 31 2022      0.01           0.01           Met